[1]
“Treatment with Cellgevity® improves glycemic index and prevents atherogenic dyslipidemia in Type 2 Diabetic rat model”, JHS, vol. 3, no. 1, pp. 24–31, Aug. 2025, Accessed: May 12, 2026. [Online]. Available: https://lasujournals.ng/index.php/jhs/article/view/75